EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte Studie

Polycaprolactone versus collagen membrane and 1‐year clinical outcomes: A randomized controlled trial

Thun Kusirisin iD, Jintamai Suwanprateeb iD, Borvornwut Buranawat iD

Clinical Implant Dentistry and Related Research · 2023-04 · 25 (2) · 330-342

DOI: 10.1111/cid.13166 ↗

At a glance

Randomisierte kontrollierte Studie in Clinical Implant Dentistry and Related Research, published online on 2022-12-15. Written by Thun Kusirisin and 2 co-authors. Institution: Department of Implantology, Faculty of Dentistry, Thammasat University, Pathum Thani, Thailand. Major MEDLINE topics: Dental Implants, Single-Tooth. Cited 12 times so far (Crossref); 43 references. Funded by: Thammasat University-National Science and Technology Development Agency, Thammasat University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Polycaprolactone (PCL) is a synthetic aliphatic polyester widely used in biomedical applications with biodegradability in the body and promotes cell proliferation and differentiation. A newly developed bilayered PCL membrane was developed for possibly being used as a membrane in guided bone regeneration (GBR).

Purpose

To compare the clinical efficacy between a newly developed bilayered PCL membrane with a Cytoplast™ RTM collagen membrane for GBR with simultaneous implant placement. Materials and Methods Twenty‐four patients were randomized to PCL or RTM group, and a total of 24 dental implants were placed. Primary outcomes were patient mean buccal bone thickness (BBT) immediately postimplantation and at 6 months using cone‐beam CT and soft tissue surface dimensional changes (STC) at crown insertion, 6 months, and 1 year after loading using intraoral scanner. Secondary outcomes included success rate, clinical parameters, healing index, implant stability, pink esthetic score, and marginal bone levels.

Results

The percentage of reduced BBT at 6 months was 32.38%, 25.94%, and 23.96% in the test group and 34.42%, 14.75%, and 6.34% in the control group at the corresponding levels. The mean difference of changed BBT associated with PCL membrane, when compared to collagen membrane, at 6 months was −0.02 ± 0.18 mm (95% confidence interval [CI]: −0.40 to 0.35), 0.29 ± 0.28 mm (95% CI: −0.29 to 0.87), and 0.62 ± 0.38 mm (95% CI: −0.17 to 1.42) at 0, 2, and 4 mm from implant shoulder. Minimal loss of STC was observed in both groups up to 1 year of loading. The mean difference loss of surface dimensional change associated with PCL membrane, when compared to collagen membrane, at 1 year of loading was 0.31 ± 0.19 mm (95% CI: −0.07 to 0.70), 0.22 ± 0.26 mm (95% CI: −0.33 to 0.76), and 0.17 ± 0.30 mm (95% CI: −0.45 to 0.78) at 0, 2, and 4 mm from implant shoulder. None of these differences were statistically significant (unpaired t ‐test, degrees of freedom [ df ] = 22; p > 0.05).

Conclusion

Within the limits of this trial, both barrier membranes resulted in comparable outcomes for GBR with implant placement after 1 year in function. Further research is necessary with a larger sample size.

Subjects

MeSH terms (MEDLINE)

Dental Implants, Single-ToothHumansEsthetics, DentalDental Implantation, EndosseousTreatment OutcomePolyestersCollagenBone Regeneration

Author keywords

bone regenerationcone-beam computed tomographydental implantsdimensional changesmembranepolycaprolactonerandomized controlled trial

Substances

polycaprolactonePolyestersCollagen

Authors and institutions

  • Department of Implantology, Faculty of Dentistry, Thammasat University, Pathum Thani, Thailand.
  • Biofunctional Materials and Devices Research Group, National Metal and Materials Technology Center, National Science and Technology Development Agency, Pathum Thani, Thailand.

ORCID profiles: Thun Kusirisin, Jintamai Suwanprateeb, Borvornwut Buranawat

Funding

  • Thammasat University-National Science and Technology Development Agency
  • Thammasat University

Cite

APA

Kusirisin, T., Suwanprateeb, J., & Buranawat, B. (2023). Polycaprolactone versus collagen membrane and 1‐year clinical outcomes: A randomized controlled trial. Clinical Implant Dentistry and Related Research, 25(2), 330-342. https://doi.org/10.1111/cid.13166

Vancouver

Kusirisin T, Suwanprateeb J, Buranawat B. Polycaprolactone versus collagen membrane and 1‐year clinical outcomes: A randomized controlled trial. Clinical Implant Dentistry and Related Research. 2023;25(2):330-342. doi:10.1111/cid.13166

BibTeX
@article{Kusirisin2023,
  author = {Kusirisin, Thun and Suwanprateeb, Jintamai and Buranawat, Borvornwut},
  title = {Polycaprolactone versus collagen membrane and 1‐year clinical outcomes: A randomized controlled trial},
  journal = {Clinical Implant Dentistry and Related Research},
  year = {2023},
  volume = {25},
  number = {2},
  pages = {330--342},
  doi = {10.1111/cid.13166}
}
Start for free →